pepsin

pepsin
Name	Pepsin
EC number	3.4.23.1
CAS number	9001-75-6
Other names	Endopeptidase A, Gastric protease
Source	Gastric mucosa (vertebrates)
Optimal pH	~1.5–2.5
Subunit	Single-chain zymogen (pepsinogen) cleaved to active form
Activity	Preferential cleavage at aromatic amino acids

pepsin is a principal gastric endopeptidase responsible for proteolysis in the acidic lumen of vertebrate stomachs. Discovered in the 19th century and characterized biochemically in subsequent decades, pepsin catalyzes peptide bond hydrolysis, participates in nutritional protein digestion, and has influenced fields ranging from Physiology to Biotechnology. Its physiological role and pathological mislocalization inform clinical syndromes and therapeutic strategies.

Structure and Properties

Pepsin is a single-chain aspartic protease with a molecular weight of ~34 kDa characterized by two lobes forming a bilobed structure containing the catalytic dyad. Structural studies by X-ray crystallography and comparisons to HIV-1 protease, Renin, Cathepsin D, Plasmepsin, and other aspartic proteases revealed conserved core architecture, active site aspartates, and substrate-binding subsites. Sequence conservation and domain arrangement link pepsin to members of the A1 peptidase family studied across taxa, including comparisons with Saccharomyces cerevisiae vacuolar proteases, Drosophila melanogaster digestive enzymes, and proteases from Homo sapiens tissues. Pepsin’s activity is maximal at low pH and is destabilized by denaturants and temperature; its kinetic parameters (Km, kcat) have been measured in enzymology studies alongside homologs such as Porcine pepsin, Bovine pepsin, and plant aspartic proteinases used in food science. Glycosylation is typically absent, and the mature enzyme displays specificity for hydrophobic and aromatic residues, a hallmark shared with enzymes analyzed in comparative structural genomics by centers such as European Molecular Biology Laboratory and Protein Data Bank-deposited structures.

Biosynthesis and Activation

Pepsin is synthesized as the zymogen pepsinogen in gastric chief cells and secreted into the gastric lumen, a process regulated by neural and hormonal inputs including signaling from Vagus nerve, Gastrin, and paracrine inputs like Histamine from ECL cells. The zymogen contains a prosegment that inhibits the active site until acidic conditions induce autolytic removal, a mechanism elucidated in studies referencing secretory pathway work done at institutions such as Johns Hopkins University, University of Cambridge, and Max Planck Society. Comparative endocrinology links pepsinogen gene regulation to transcription factors studied in labs at Harvard University and Stanford University. Activation kinetics and trafficking through the regulated secretory pathway involve vesicle biogenesis analogous to pathways investigated in research on Pancreatic acinar cell secretion and endocrine granule formation.

Function and Mechanism of Action

Pepsin functions in initial protein digestion by cleaving internal peptide bonds preferentially at aromatic residues such as phenylalanine, tyrosine, and tryptophan, operating via a general acid–base mechanism mediated by two aspartic acid residues. Mechanistic parallels appear with aspartic proteases characterized in studies on HIV-1, Plasmodium falciparum, and Candida albicans proteases, informing inhibitor design and comparative enzymology. In vivo, pepsin acts together with gastric acid secretions regulated by pathways involving Parietal cell proton pumps targeted by drugs developed by companies like AstraZeneca and Johnson & Johnson. Physiological roles extend beyond digestion to modulation of peptide hormone availability and interactions with mucosal defenses that have been subjects of research at institutions such as Mayo Clinic and Cleveland Clinic.

Regulation and Inhibition

Pepsin activity is regulated at transcriptional, secretory, and pH-dependent levels. Acid secretion from parietal cells, modulated by neurotransmitters and hormones including Acetylcholine, Gastrin-releasing peptide, and Somatostatin, dictates the activation environment for pepsin. Pharmaceutical inhibition strategies target upstream acid production (e.g., Proton pump inhibitors developed after research at University of Dundee and Takeda Pharmaceutical Company), while direct pepsin inhibitors—many designed using structural information from Protein Data Bank entries and academic work at Massachusetts Institute of Technology and University of Oxford—include pepstatin A, small-molecule mimetics, and antibody-based approaches investigated in translational research centers. Pathogens and dietary inhibitors also interact with pepsin, with studies on Helicobacter pylori linking bacterial factors to altered pepsinogen secretion patterns documented in epidemiological research by agencies like World Health Organization.

Clinical Significance and Pathology

Aberrant pepsin activity or reflux of pepsin-containing gastric secretions contributes to pathological conditions such as gastroesophageal reflux disease (GERD), laryngopharyngeal reflux, and peptic ulcer disease. Clinical research at hospitals including Mount Sinai Hospital, Cleveland Clinic, and university medical centers has correlated pepsin detection in esophageal or laryngeal samples with mucosal injury, implicating pepsin in inflammatory cascades studied with cytokine profiling methods pioneered at institutions like Karolinska Institutet and Imperial College London. Diagnostic assays for pepsin in biological fluids have been developed in collaboration with biotech firms such as Roche and Siemens Healthineers. Therapeutically, management strategies employ acid suppression, surgical interventions developed in centers such as Mayo Clinic and Cleveland Clinic (e.g., fundoplication), and experimental protease-targeted therapies investigated in clinical trials registered by organizations like National Institutes of Health.

Industrial and Research Applications

Pepsin has utility in industrial processes and laboratory research: it is used in food processing for protein hydrolysate production, cheese manufacture, and in peptide mapping and proteomics workflows in research labs at places like Broad Institute and European Bioinformatics Institute. Commercial preparations of pepsin are produced by biopharmaceutical companies and referenced in pharmacopeias compiled by organizations such as United States Pharmacopeia and European Pharmacopoeia. Structural and inhibitor studies leveraging pepsin have informed drug discovery pipelines at pharmaceutical corporations including Pfizer and GlaxoSmithKline and academic consortia exploring enzyme engineering, directed evolution, and synthetic biology approaches led by groups at California Institute of Technology and ETH Zurich. Emerging research applies pepsin in biomaterial processing and in vitro digestion models used by food science departments at Wageningen University and Cornell University.

Category:Proteases Category:Gastric physiology Category:Enzymes